3SBio Inc. Announces Unaudited Second Quarter Results

SHENYANG, China, Aug. 17 /PRNewswire-Asia-FirstCall/ — — 2Q revenues grew 29.5% Y-o-Y to RMB105.5 million (US$15.6million) — 1H revenues grew 34.5% Y-o-Y to RMB201.9 million (US$29.8 million) — Company reiterates FY2010 revenue guidance — New plant is granted GMP certification by SFDA 3SBio Inc. (Nasdaq: SSRX) (“3SBio” or “the Company”), a leading China- based biotechnology company focused …